We have decent odds of a new 52-week low in IBM over the next few weeks.
Both BA and JNJ appear to have made decisions in which the bottom line took precedent over what they stand for as a company.
The railroad stock is primed to break out above its 200-day moving average.
As the robotics sector of medicine begins to mature, ISRG finds itself as one of the old guard.
Warren Buffett may be buying more BAC shares. Here's how to play a move higher.
I like the long call now.
The diversified manufacturing and supply chain management company holds big upside potential based on expectations of earnings ahead.
Sentiment may be too negative on Square stock now.
Shoe giant seems poised to break $100 a share, and here's a great call play to make.
JD.com separates itself from other e-commerce competitors by controlling its inventory and logistics.
I don't expect BBBY's recent post-earnings rally to last.
Partnership with Toys R Us will improve Target's dominance in the category.
I prefer to focus on companies for which I have some familiarity. That's a personal rule.
Why I'm leaning toward a trade in the former cannabis darling.
Let's use Roku as an illustration of the benefits of cash-secured ratio puts spreads.
BABA's China-driven declines have been buying opportunities.
SDC is being valued at the same multiple as competitors with significantly slower growth.
Is there room for three names in the workplace communication sector?
The focus now should be on the $65 level.
The streaming service is going to be a home run.
Apple might be setting up for a new all-time high, and this is a forgone conclusion if the market makes another leg higher.
The chart on Chewy is one ugly mutt, there's no denying it, but the price action turned this week.
These guys are going to make a lot of money by moving to this route.
October is a scary month, but the cloud sector had its comeuppance during September.
Bonds are an interesting trade right now.
It's tough to get overly aggressive, but if the company should fall, say another 25%, it might be too hard for growth investors to pass up.
Camping World and American Airlines have had tough years but looks like call option candidates as their prospects improve.
Several factors could set us up for a bounce play in a grossly oversold name.
BABA's rebound is far from over.
The SPDR S&P Biotech ETF, Alexion Pharmaceuticals and BioMarin Pharmaceuticals set up nicely for this options strategy.